Last update 01 Nov 2024

TT-00434

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms-
Target
FGFR1 x FGFR2 x FGFR3
Mechanism
FGFR1 antagonists(Fibroblast growth factor receptor 1 antagonists), FGFR2 antagonists(Fibroblast growth factor receptor 2 antagonists), FGFR3 antagonists(Fibroblast growth factor receptor 3 antagonists)
Therapeutic Areas
NeoplasmsDigestive System Disorders
Active Indication
Advanced Malignant Solid NeoplasmStomach Cancer
Inactive Indication-
Originator Organization
TransThera Sciences (Nanjing), Inc.TransThera Sciences (Nanjing), Inc.Startup
Active Organization
TransThera Sciences (Nanjing), Inc.TransThera Sciences (Nanjing), Inc.Startup
Inactive Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with TT-00434
NCT04830501 / CompletedPhase 1
A Phase I Study of the Safety, Tolerability, Pharmacokinetics Profile, and Preliminary Efficacy of TT-00434 in Patients With Advanced Solid Tumors
100 Clinical Results associated with TT-00434
Login to view more data
100 Translational Medicine associated with TT-00434
Login to view more data
100 Patents (Medical) associated with TT-00434
Login to view more data
100 Deals associated with TT-00434
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced Malignant Solid NeoplasmPhase 1
TW
TransThera Sciences (Nanjing), Inc.TransThera Sciences (Nanjing), Inc.Startup
12 Jul 2021
Stomach CancerPhase 1
US
TransThera Sciences (Nanjing), Inc.TransThera Sciences (Nanjing), Inc.Startup
-
Stomach CancerPhase 1
CN
TransThera Sciences (Nanjing), Inc.TransThera Sciences (Nanjing), Inc.Startup
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
NCT04830501 (ESMO_ASIA2023)
ManualManual
Phase 1
Advanced Malignant Solid Neoplasm
11
(xzcoyfrlta) = lfdfkzfypg ulfocgtcbu (zwvutjgrij )
View more
Positive
02 Dec 2023
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free